Table 1.
Study Period Cohort (N=2068) | Control Period Cohort Subset (N=672) | ||||
---|---|---|---|---|---|
| |||||
N | % | N | % | ||
Sex | Female | 729 | 35% | 276 | 41% |
Male | 1339 | 65% | 396 | 59% | |
| |||||
Race/ethnicity | Black non-Hispanic | 1403 | 68% | 522 | 78% |
Hispanic | 354 | 17% | 85 | 13% | |
White non-Hispanic | 276 | 13% | 63 | 9% | |
Other | 35 | 2% | 2 | 0% | |
| |||||
Year of visit | 2009 (2004 for Control) | 600 | 29% | 58 | 9% |
2010 (2005 for Control) | 602 | 29% | 107 | 16% | |
2011 (2006 for Control) | 440 | 21% | 140 | 21% | |
2012 (2007 for Control) | 426 | 21% | 367 | 54% | |
| |||||
Age group | 16–24 | 86 | 4% | 31 | 5% |
25–34 | 401 | 19% | 137 | 20% | |
35–44 | 661 | 32% | 261 | 39% | |
45–54 | 656 | 32% | 190 | 28% | |
55+ | 264 | 13% | 53 | 8% | |
| |||||
Years since diagnosis | 1–5 | 627 | 30% | 186 | 28% |
6–10 | 516 | 25% | 221 | 33% | |
11–15 | 484 | 23% | 165 | 25% | |
16–20 | 274 | 13% | 76 | 11% | |
21+ | 167 | 13% | 24 | 4% | |
| |||||
Total | 2068 | 100% | 672 | 100% |